Vittoria Borgonetti, Paolo Governa*, Monica Montopoli and Marco Biagi Pages 147 - 158 ( 12 )
The interest in Cannabis sativa L. phytocomplex as a medicinal tool is a recently-emerging topic. Neurodegenerative diseases represent a promising field of application for cannabis and its preparations, as most of this pathologic conditions relies on an inflammatory etiology. Several cannabis constituents display anti-inflammatory effects targeting multiple pathways. In this review, a comprehensive overview of the available literature on C. sativa constituents activities in neuroinflammation is given. On the basis that the anti-inflammatory activity of cannabis is not attributable to only a single constituent, we discuss the possible advantages of administering the whole phytocomplex in order to fully exploit the “entourage effect” in neuroinflammatory-related conditions.
Cannabis sativa L., neuroinflammation, cannabinoids, caryophyllene, apigenin, microglia, endocannabinoid system, phytotherapy.
SIFITLab, Via Laterina 8, 53100 Siena, SIFITLab, Via Laterina 8, 53100 Siena, SIFITLab, Via Laterina 8, 53100 Siena, SIFITLab, Via Laterina 8, 53100 Siena